Qube Research & Technologies LTD Amneal Pharmaceuticals, Inc. Transaction History
Qube Research & Technologies LTD
- $62.3 Billion
- Q2 2024
A detailed history of Qube Research & Technologies LTD transactions in Amneal Pharmaceuticals, Inc. stock. As of the latest transaction made, Qube Research & Technologies LTD holds 640,907 shares of AMRX stock, worth $5.65 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
640,907
Previous 490,874
30.56%
Holding current value
$5.65 Million
Previous $2.97 Million
36.82%
% of portfolio
0.01%
Previous 0.0%
Shares
13 transactions
Others Institutions Holding AMRX
# of Institutions
186Shares Held
137MCall Options Held
234KPut Options Held
45.9K-
Ubs Group Ag21.8MShares$192 Million0.03% of portfolio
-
Vanguard Group Inc Valley Forge, PA14MShares$123 Million0.0% of portfolio
-
Tpg Gp A, LLC Fort Worth, TX12.3MShares$109 Million1.95% of portfolio
-
Black Rock Inc. New York, NY11.3MShares$99.4 Million0.0% of portfolio
-
Rubric Capital Management LP New York, NY10.7MShares$94.5 Million2.02% of portfolio
About Amneal Pharmaceuticals, Inc.
- Ticker AMRX
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 151,408,992
- Market Cap $1.33B
- Description
- Amneal Pharmaceuticals, Inc., together with its subsidiaries, develops, licenses, manufactures, markets, and distributes generic and specialty pharmaceutical products for various dosage forms and therapeutic areas. The company operates through three segments: Generics, Specialty, and AvKARE. The Generics segment develops, manufactures, and comme...